Healthcare Services company Inventurus Knowledge Solutions announced Q2FY26 results Revenue: Rs 7,811 million compared to Rs 6,428 million during Q2FY25, change 22%. EBITDA: Rs 2,718 million compared to Rs 1,898 million during Q2FY25, change 43%. PAT: Rs 1,807 million compared to Rs 1,130 million during Q2FY25, change 60%. Sachin K. Gupta, Founder & Global CEO, IKS Health, said: “The second quarter was a period of significant strategic execution and strong financial performance for IKS Health. Our results underscore the growing market demand for our Care Enablement Platform as health systems increasingly recognize the need to holistically address administrative, clinical, and financial challenges.” “A key highlight of this quarter was the launch of our Agentic AI platform on Google Cloud and native integration of Scribble Now, our ambient AI scribing solution, into revenue cycle management, coding, and clinical documentation workflows, creating the industry’s first connected encounter-to-reimbursement platform and winning the 2025 Dora Award from Google Cloud Award for ‘Augmenting Human Expertise with AI’. We have also significantly accelerated the execution of our AI strategy, marked by the appointment of our new Chief AI Officer. These accomplishments reflect our unwavering commitment to augmenting human expertise to deliver unparalleled clinical, financial, and operational excellence to our clients." Nithya Balasubramanian, Group CFO, IKS Health said: “IKS Health’s strong Q2FY26 financial performance, highlighted by a 22% YoY Revenue, 43% EBITDA and 60% PAT growth reflects our continued focus on driving consistent, profitable growth. The improvement in our EBITDA margin showcases the scalability of our platform and disciplined capital management. As we progress, we will maintain this balanced approach—preserving margin strength while investing strategically to support sustainable growth and long-term shareholder value.” Result PDF
Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.